Topic
Broadcom Research
Research regarding Broadcom centers on an 'astonishing' ramp-up in global AI demand, with the total addressable market for AI data center systems projected to reach $1.7 trillion by CY30. This momentum is further validated by South Korea's semiconductor exports, which surged 169.4% due to sustained global AI investment. While the accelerator market remains competitive, the broader semiconductor landscape is benefiting from a cyclical recovery in the analog sector and emerging growth in AI power semiconductors. However, institutional sentiment suggests some tactical caution, as UBS recommends rebalancing away from concentrated US tech holdings amid geopolitical volatility and a 12.4% year-to-date return. Despite these macro pressures and a 'K-shaped' consumer recovery, the anticipated shift by central banks toward growth-oriented policies in late 2026 provides a supportive backdrop for infrastructure leaders. Consequently, the research direction highlights a massive expansion in AI-related hardware demand balanced against regional currency pressures and portfolio diversification trends.
4277 reports available
All reports
Page 71 of 179
Early Morning Reid
Deutsche Bank · Jun 9, 2026
Apple Another AI Attempt At WWDC
Barclays · Jun 9, 2026
Will the IPO Wave Derail Equities
Deutsche Bank · Jun 9, 2026
Daily Europe
UBS · Jun 9, 2026
Inside Commodities
London Stock Exchange Group · Jun 9, 2026
US Equities Color Broadening
Goldman Sachs & Co. LLC · Jun 9, 2026
The 720 Japan Tech China Internet And Corporate Strategy Updates
Goldman Sachs · Jun 9, 2026
Oscar Health Inc Key Takeaways
Goldman Sachs · Jun 9, 2026
EU Energy Sector Specialist Commentary
J.P. Morgan · Jun 9, 2026
The Point For Europe
Citi · Jun 9, 2026
Innoviva Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
Research Unplugged: Data Centers and Behind the Meter Solutions
Goldman Sachs · Jun 9, 2026
GS Sustain: The Reliability Imperative
Goldman Sachs · Jun 9, 2026
Global Macro Monthly
TS Lombard · Jun 9, 2026
Sino Biopharmaceutical Key Takeaways
Goldman Sachs · Jun 9, 2026
Teva Pharmaceuticals Annual Global Healthcare Conference Key Takeaways
Goldman Sachs · Jun 9, 2026
Tandem Diabetes Care Inc. Key Takeaways
Goldman Sachs · Jun 9, 2026
GS Basics - Token Expenditure Apple Monetization Debate
Goldman Sachs · Jun 9, 2026
Hemab Therapeutics Holdings Strategic Interests and Market Opportunity in VWD
Goldman Sachs · Jun 9, 2026
Seaport Therapeutics Additional Phase 1 Data Validates the Glyph Platform
Goldman Sachs · Jun 9, 2026
Turkiye Banks Sector Trends
Goldman Sachs · Jun 9, 2026
Sarepta Therapeutics Key Takeaways
Goldman Sachs · Jun 9, 2026
Marketcolour and CPI Preview
Goldman Sachs · Jun 9, 2026
Barclays Equity Factor Insights
Barclays · Jun 9, 2026